Suven Pharmaceuticals Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sales

1,330.08

1,320.22

1,009.72

833.79

377.83

Operating profit

583.08

579.99

440.52

385.15

171.55

Interest

5.39

6.23

9.14

21.81

2.79

Gross profit

622.24

761.55

445.62

381.45

169.36

EPS (Rs)

16.99

21.92

12.12

21.22

8.59

Other income

44.55

187.79

14.24

18.12

0.60

Stock adjustment

-20.94

-60.35

-8.37

-11.05

-21.32

Raw material

421.36

459.46

310.32

240.24

124.52

Power and fuel

-

-

-

-

-

Employee expenses

100.84

100.48

76.23

73.72

29.63

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

8.59

10.35

11.06

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

237.16

230.29

179.96

145.73

73.45

Provisions made

-

-

-

-

-

Depreciation

42.84

39.10

31.64

23.86

11.50

Taxation

146.79

164.35

105.33

87.51

48.59

Net profit / loss

432.60

558.10

308.65

270.08

109.27

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

25.46

25.46

25.46

12.73

12.73

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

43.84

43.93

43.63

46.19

45.40

GPM (%)

45.27

50.50

43.52

44.78

44.75

NPM (%)

31.47

37.01

30.14

31.70

28.88